• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼内肿瘤溶解破坏模式的免疫学分析

Immunological analysis of a destructive pattern of intraocular tumor resolution.

作者信息

Niederkorn J Y, Knisely T L

机构信息

Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas 75235-9057.

出版信息

Curr Eye Res. 1988 May;7(5):515-26. doi: 10.3109/02713688809031806.

DOI:10.3109/02713688809031806
PMID:3409718
Abstract

Spontaneous rejection of syngeneic intraocular P91 mastocytoma occurred by a T cell-dependent immune process that produced extensive, irreparable damage to normal ocular tissue indicative of a delayed-type hypersensitivity (DTH) lesion. We investigated the contribution of other effector modalities in this tumor resolution. Antibody was not responsible for either tumor rejection of phthisis of the tumor-containing eye since passively transferred hyperimmune serum failed to produce either tumor rejection or the characteristic ocular lesions. Moreover, the destructive pattern of tumor rejection occurred in splenectomized hosts which had depressed anti-P91 serum antibody and in a congenic strain (B10.D2oSn) lacking the C5 complement component. The likelihood that tumor necrosis factor (TNF) was involved in this pathogenesis was also ruled out by the observation that P91 tumor cells were not susceptible to lysis by recombinant TNF. A different pattern of tumor resolution was observed when the opposite eye was challenged with tumor. In this case, the tumor was rejected without damaging any major ocular structures. Histological analysis demonstrated a mononuclear cellular infiltrate which was identified by immunohistology to be Thy 1+, Lyt 2+. Thus, although both forms of cell-mediated immunity are available to the host, only one predominated in each eye. These results suggest that unique immunological control mechanisms influence the outcome of tumor resolution in the eye.

摘要

同基因眼内P91肥大细胞瘤的自发排斥是由T细胞依赖性免疫过程介导的,该过程对正常眼组织造成了广泛的、不可修复的损伤,提示为迟发型超敏反应(DTH)病变。我们研究了其他效应方式在该肿瘤消退过程中的作用。抗体对含瘤眼的肿瘤排斥或眼球痨均无作用,因为被动转移的超免疫血清未能引起肿瘤排斥或特征性的眼部病变。此外,肿瘤排斥的破坏模式发生在脾切除的宿主中,这些宿主的抗P91血清抗体水平降低,且发生在缺乏C5补体成分的同基因品系(B10.D2oSn)中。P91肿瘤细胞对重组TNF不敏感这一观察结果也排除了肿瘤坏死因子(TNF)参与该发病机制的可能性。当对侧眼用肿瘤进行攻击时,观察到了不同的肿瘤消退模式。在这种情况下,肿瘤被排斥,而未损伤任何主要的眼部结构。组织学分析显示有单核细胞浸润,免疫组织化学鉴定为Thy 1+、Lyt 2+。因此,尽管宿主可利用两种形式的细胞介导免疫,但每只眼中只有一种占主导。这些结果表明,独特的免疫控制机制影响眼内肿瘤消退的结果。

相似文献

1
Immunological analysis of a destructive pattern of intraocular tumor resolution.眼内肿瘤溶解破坏模式的免疫学分析
Curr Eye Res. 1988 May;7(5):515-26. doi: 10.3109/02713688809031806.
2
Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.同基因眼内肿瘤免疫排斥的破坏性和非破坏性模式。
J Immunol. 1987 Jun 15;138(12):4515-23.
3
Spontaneous immune rejection of intraocular tumors in mice.小鼠眼内肿瘤的自发免疫排斥反应。
Invest Ophthalmol Vis Sci. 1985 Jun;26(6):877-84.
4
Anti-leukocyte function-1 antibody treatment prevents the rejection of intraocular regressor tumors and their metastases.抗白细胞功能-1抗体治疗可预防眼内消退性肿瘤及其转移灶的排斥反应。
Curr Eye Res. 1995 Aug;14(8):719-26. doi: 10.3109/02713689508998500.
5
The immunopathology of intraocular tumour rejection.眼内肿瘤排斥反应的免疫病理学
Eye (Lond). 1991;5 ( Pt 2):186-92. doi: 10.1038/eye.1991.33.
6
Immune rejection of metastases arising from intraocular tumors in mice.
Invest Ophthalmol Vis Sci. 1986 Sep;27(9):1355-61.
7
CD8+ T cells circumvent immune privilege in the eye and mediate intraocular tumor rejection by a TNF-alpha-dependent mechanism.CD8 + T细胞可绕过眼部的免疫赦免,并通过肿瘤坏死因子-α依赖机制介导眼内肿瘤排斥反应。
J Immunol. 2007 May 15;178(10):6115-22. doi: 10.4049/jimmunol.178.10.6115.
8
Immunologic evaluation of spontaneous regression of an intraocular murine melanoma.眼内小鼠黑色素瘤自发消退的免疫学评估
Invest Ophthalmol Vis Sci. 1990 Feb;31(2):247-57.
9
Promotion of syngeneic intraocular tumor growth in mice by anterior chamber-associated immune deviation.前房相关免疫偏离促进小鼠同基因眼内肿瘤生长
J Natl Cancer Inst. 1983 Jul;71(1):193-9.
10
Requirement of CD80+ costimulation for rejection of ocular tumors and termination of immune privilege.CD80+共刺激对眼部肿瘤排斥及免疫赦免终止的需求。
Exp Eye Res. 2006 Sep;83(3):574-83. doi: 10.1016/j.exer.2006.02.009. Epub 2006 Apr 27.

引用本文的文献

1
IFN-γ-independent intraocular tumor rejection is mediated by a macrophage-dependent process that leaves the eye intact.干扰素-γ 非依赖性眼内肿瘤排斥反应是由巨噬细胞依赖性过程介导的,该过程使眼睛保持完整。
J Leukoc Biol. 2012 Nov;92(5):939-50. doi: 10.1189/jlb.0312122. Epub 2012 Jun 12.
2
IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.依赖于白介素-17(IL-17)、干扰素-γ(IFN-γ)的肿瘤排斥反应是由细胞毒性 T 淋巴细胞介导的,发生在眼外部位,但被排除在眼睛之外。
J Immunol. 2011 Oct 15;187(8):4219-28. doi: 10.4049/jimmunol.1100826. Epub 2011 Sep 14.
3
Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors.
阻断 TNF-α 的表达可预防 iNOS 介导的眼内肿瘤消除过程中对正常组织的旁观者损伤。
Cancer Res. 2011 Apr 1;71(7):2445-54. doi: 10.1158/0008-5472.CAN-10-2628. Epub 2011 Feb 9.
4
Influence of immune privilege on ocular tumor development.免疫特权对眼肿瘤发生的影响。
Ocul Immunol Inflamm. 2010 Apr;18(2):80-90. doi: 10.3109/09273941003669950.
5
Immune escape mechanisms of intraocular tumors.眼内肿瘤的免疫逃逸机制
Prog Retin Eye Res. 2009 Sep;28(5):329-47. doi: 10.1016/j.preteyeres.2009.06.002. Epub 2009 Jun 27.
6
Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.转化生长因子-β下调主要组织相容性复合体I类抗原表达,并增加葡萄膜黑色素瘤细胞对自然杀伤细胞介导的细胞溶解的敏感性。
Immunology. 1995 Oct;86(2):263-9.
7
Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye.从眼眼前房肿瘤浸润细胞中产生占主导地位的细胞毒性T淋巴细胞抗肿瘤效应细胞。
Cancer Immunol Immunother. 1990;30(6):323-30. doi: 10.1007/BF01786881.
8
Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens.眼前房的免疫赦免:同时呈递至前房的同种异体抗原和肿瘤特异性抗原可诱导对相应抗原的迟发型超敏反应的抑制和激活。
Immunology. 1992 Oct;77(2):189-95.